Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD

NCT05107752 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT05107752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05107752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD
Lead sponsor
Ohio State University
Phase
Phase 2
Overall status
Completed
Start date
January 3, 2022
Completion date
March 31, 2025
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder, ptsd, trauma and stressor related disorders, trauma, psychological